Release of eicosanoids from human synovial tissue and the effect of anti-inflammatory drugs.
D000636:Aminosalicylic Acids / Q000494:pharmacology*; D000818:Animals; D000001:Calcimycin / Q000494:pharmacology; D002867:Chromones / Q000494:pharmacology*; D006168:Guinea Pigs; D006801:Humans; D066298:In Vitro Techniques; D007213:Indomethacin / Q000494:pharmacology*; D019804:Mesalamine; D009119:Muscle Contraction / Q000187:drug effects; D011453:Prostaglandins / Q000378:metabolism*; D013189:SRS-A / Q000037:antagonists & inhibitors*; D013424:Sulfanilamides / Q000494:pharmacology*; D013427:Sulfapyridine / Q000494:pharmacology*; D013583:Synovial Membrane / Q000187:drug effects / Q000378:metabolism*
D000636:Aminosalicylic Acids; D002867:Chromones; D011453:Prostaglandins; D013189:SRS-A; D013424:Sulfanilamides; D000001:Calcimycin; D019804:Mesalamine; C006312:FPL 55712; D007213:Indomethacin; D013427:Sulfapyridine